Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H29N |
| Molecular Weight | 295.4617 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)N(CCC(C1=CC=CC=C1)C2=CC=CC=C2)C(C)C
InChI
InChIKey=YBJKOPHEJOMRMN-UHFFFAOYSA-N
InChI=1S/C21H29N/c1-17(2)22(18(3)4)16-15-21(19-11-7-5-8-12-19)20-13-9-6-10-14-20/h5-14,17-18,21H,15-16H2,1-4H3
Diisopromine, a spasmolytic and a choleretic, in combination with sorbitol was marketed under the brand name Agofell. Agofell is prescribed for the biliary stasis and biliary insufficiency, hypotonia of the gall bladder, spasm of the biliary duct and of the sphincter of Oddi, cholecystitis, cholelithiasis, post cholecystotomy syndrome.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29696
Created by
admin on Mon Mar 31 18:24:15 GMT 2025 , Edited by admin on Mon Mar 31 18:24:15 GMT 2025
|
||
|
WHO-VATC |
QA03AX02
Created by
admin on Mon Mar 31 18:24:15 GMT 2025 , Edited by admin on Mon Mar 31 18:24:15 GMT 2025
|
||
|
WHO-ATC |
A03AX02
Created by
admin on Mon Mar 31 18:24:15 GMT 2025 , Edited by admin on Mon Mar 31 18:24:15 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C80978
Created by
admin on Mon Mar 31 18:24:15 GMT 2025 , Edited by admin on Mon Mar 31 18:24:15 GMT 2025
|
PRIMARY | |||
|
SUB07143MIG
Created by
admin on Mon Mar 31 18:24:15 GMT 2025 , Edited by admin on Mon Mar 31 18:24:15 GMT 2025
|
PRIMARY | |||
|
m694
Created by
admin on Mon Mar 31 18:24:15 GMT 2025 , Edited by admin on Mon Mar 31 18:24:15 GMT 2025
|
PRIMARY | Merck Index | ||
|
100000082608
Created by
admin on Mon Mar 31 18:24:15 GMT 2025 , Edited by admin on Mon Mar 31 18:24:15 GMT 2025
|
PRIMARY | |||
|
227-752-4
Created by
admin on Mon Mar 31 18:24:15 GMT 2025 , Edited by admin on Mon Mar 31 18:24:15 GMT 2025
|
PRIMARY | |||
|
236206
Created by
admin on Mon Mar 31 18:24:15 GMT 2025 , Edited by admin on Mon Mar 31 18:24:15 GMT 2025
|
PRIMARY | RxNorm | ||
|
Diisopromine
Created by
admin on Mon Mar 31 18:24:15 GMT 2025 , Edited by admin on Mon Mar 31 18:24:15 GMT 2025
|
PRIMARY | |||
|
DTXSID60208343
Created by
admin on Mon Mar 31 18:24:15 GMT 2025 , Edited by admin on Mon Mar 31 18:24:15 GMT 2025
|
PRIMARY | |||
|
22262
Created by
admin on Mon Mar 31 18:24:15 GMT 2025 , Edited by admin on Mon Mar 31 18:24:15 GMT 2025
|
PRIMARY | |||
|
989
Created by
admin on Mon Mar 31 18:24:15 GMT 2025 , Edited by admin on Mon Mar 31 18:24:15 GMT 2025
|
PRIMARY | |||
|
DB13476
Created by
admin on Mon Mar 31 18:24:15 GMT 2025 , Edited by admin on Mon Mar 31 18:24:15 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110849
Created by
admin on Mon Mar 31 18:24:15 GMT 2025 , Edited by admin on Mon Mar 31 18:24:15 GMT 2025
|
PRIMARY | |||
|
892
Created by
admin on Mon Mar 31 18:24:15 GMT 2025 , Edited by admin on Mon Mar 31 18:24:15 GMT 2025
|
PRIMARY | |||
|
2825S6AW9U
Created by
admin on Mon Mar 31 18:24:15 GMT 2025 , Edited by admin on Mon Mar 31 18:24:15 GMT 2025
|
PRIMARY | |||
|
5966-41-6
Created by
admin on Mon Mar 31 18:24:15 GMT 2025 , Edited by admin on Mon Mar 31 18:24:15 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
